Inhibition of RAW264.7 macrophage inflammatory cytokines release by small haparin RNAi targeting TLR4

Abstract

In order to construct an expression vector carrying small hairpin (sh) RNA (shRNA) for toll-like receptor 4 mRNA and a reporter gene of enhanced green fluorescence protein (EGFP) and study the inhibition of cytokine release by RAW264.7 cell induced by lipopolysaccharide (LPS) stimulation through transfection and expression of shRNA targeting TLR4 gene via the RNAi mechanism, the reporter gene plasmid pEGFP-C1 (4.7 kb) and psiRNA-hH1neo (2979 bp) were used. The H1 promotor and double Bbs: restrict endoenzyme site were cloned from plasmid psiRNA-hH1neo and reconstructed them into plasmid pEGFP-C1 in the Mlu: restrict endoenzymic site, forming plasmid pEGFP-H1/siRNA, which contained Bbs site and reporter EGFP gene. Then an oligonuclear hairpin sequence targeting TLR4 gene was designed by internet tool and inserted into the plasmid pEGFP-H1/siRNA forming plasmid pEGFP-H1/TLR4-siRNA. After transfection of pEGFP-H1/TLR4-siRNA into RAW264.7 cells, tumor necrosis factor-alpha (TNF-α) release by the cells after stimulation by LPS was detected. The results showed that the constructed pEGFP-H1/TLR4-siRNA carrying hairpin RNA for TLR4 gene and reporter EGFP gene were proven to be right by restriction endonuclease analysis. The expression of EGFP gene was (50.37±8.23) % and after transfection of the plasmid pEGFP-H1/ TLR4-siRNA the level of TNF-α released by RAW264.7 cell was down regulated. It was concluded that shRNA targeting TLR4 gene could inhibit the TNF-α release by RAW264.7 cells evoked by LPS.

Keywords

RNA interference / lipopolysaccharide / macrophage / toll-like receptor 4

References

[1] HannonG. J.. RNA interference. Nature, 2002, 418(6894): 244-251

[2] BrummelkampT. R., BernardsR., AgamiR.. A system for stable expression of short interfering RNAi in mammalian cells. Science, 2002, 296(55676): 550-553

[3] SawaY., MorishitaR., SuzukiK., et al.. A novel strategy for myocardial protection using in vivo transfection of cis element “decoy” against NF kappa B binding site: evidence for a role of NF kappa B in ischemia-reperfusion injury. Circulation, 1997, 96(9Suppl): 280-284

[4] YuS. M., WuJ. F., LinT. L., et al.. Inhibition of nitric oxide synthase expression by PPM-18, a novel anti-inflammatory agent, in vitro and in vivo. Biochem J, 1997, 328: 363-369

[5] ElbashirS. M., HarborthJ., LendeckelW., et al.. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411(6836): 494-498

[6] BernsteinE., HammondS. M., HannonG. J.. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature, 2001, 409(6818): 363-366

[7] WellsC. A., RavasiT., HumeD. A.. Inflammation suppressor genes: please switch out all the lights. J Leukoc Biol, 2005, 78(1): 9-13

[8] LienE., MeansT. K., HeineH., et al.. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest, 2000, 105(4): 497-504

[9] TakedaK., AkiraS.. Toll receptors and pathogen resistance. Cell Microbiol, 2003, 5(3): 143-153

[10] JohnsonG. B., BrunnG. J., KodairaY., et al.. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol, 2002, 168(10): 5233-5239

[11] MantovaniA., LocatiM., PolentaruttiN., et al.. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. J Leukoc Biol, 2004, 75(5): 738-742

[12] GallucciS., MatzingerP.. Danger signals: SOS to the immune system. Curr Opin Immunol, 2001, 13(1): 114-119

[13] RaeburnC. D., CalkinsC. M., ZimmermanM. A., et al.. Toll-like receptors and surgical disease. Surgery, 2002, 131(5): 477-483

[14] LiJ., CaoZ. W., ZhangS. C., et al.. Effect of antisense Toll-like receptor 4 expressing plasmids mouse macrophages stimulated by endotoxin. J Fudan (Medical Sciences, Chinese), 2004, 31(3): 251-253

[15] PhamJ. W., PellinoJ. L., LeeY. S., et al.. A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila. Cell, 2004, 117(1): 83-94